A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 ...

Research also suggests untreated sleep apnea is linked to a heightened risk of Parkinsons disease, a movement disorder ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Sleep apnea is a common sleep disorder that causes abnormal breathing ...

Patients with obstructive sleep apnea appear to be at greater risk for kidney and bladder cancer. Obstructive sleep apnea is associated with a higher risk for kidney and bladder cancer, but not ...

Obstructive sleep apnea, a condition that causes lower oxygen levels during sleep, is linked to degeneration of brain regions associated with memory through damage to the brain's small blood vessels, ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

You can live for years with obstructive sleep apnea and never know it. The condition repeatedly narrows your upper airway during sleep.